Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in human immunodeficiency virus-infected pediatric patients.
about
Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countriesPharmacotherapy of pediatric and adolescent HIV infectionPharmacokinetic optimization of antiretroviral therapy in children and adolescents.Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges.
P2860
Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in human immunodeficiency virus-infected pediatric patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Steady-state pharmacokinetics ...... s-infected pediatric patients.
@en
Steady-state pharmacokinetics ...... s-infected pediatric patients.
@nl
type
label
Steady-state pharmacokinetics ...... s-infected pediatric patients.
@en
Steady-state pharmacokinetics ...... s-infected pediatric patients.
@nl
prefLabel
Steady-state pharmacokinetics ...... s-infected pediatric patients.
@en
Steady-state pharmacokinetics ...... s-infected pediatric patients.
@nl
P2093
P2860
P1476
Steady-state pharmacokinetics ...... s-infected pediatric patients.
@en
P2093
Andrew Wiznia
Bobbie Graham
Douglas Watson
Edward P Acosta
Jennifer R King
Joyce Kraimer
Patrick Jean-Philippe
Paula Britto
Vincent Carey
P2860
P304
P356
10.1097/INF.0B013E3181861D8B
P50
P577
2009-02-01T00:00:00Z